96 related articles for article (PubMed ID: 20170186)
1. 1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.
Micheli F; Cavanni P; Arban R; Benedetti R; Bertani B; Bettati M; Bettelini L; Bonanomi G; Braggio S; Checchia A; Davalli S; Di Fabio R; Fazzolari E; Fontana S; Marchioro C; Minick D; Negri M; Oliosi B; Read KD; Sartori I; Tedesco G; Tarsi L; Terreni S; Visentini F; Zocchi A; Zonzini L
J Med Chem; 2010 Mar; 53(6):2534-51. PubMed ID: 20170186
[TBL] [Abstract][Full Text] [Related]
2. 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.
Micheli F; Cavanni P; Andreotti D; Arban R; Benedetti R; Bertani B; Bettati M; Bettelini L; Bonanomi G; Braggio S; Carletti R; Checchia A; Corsi M; Fazzolari E; Fontana S; Marchioro C; Merlo-Pich E; Negri M; Oliosi B; Ratti E; Read KD; Roscic M; Sartori I; Spada S; Tedesco G; Tarsi L; Terreni S; Visentini F; Zocchi A; Zonzini L; Di Fabio R
J Med Chem; 2010 Jul; 53(13):4989-5001. PubMed ID: 20527970
[TBL] [Abstract][Full Text] [Related]
3. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
4. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
[TBL] [Abstract][Full Text] [Related]
5. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
[TBL] [Abstract][Full Text] [Related]
6. In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor.
Aluisio L; Lord B; Barbier AJ; Fraser IC; Wilson SJ; Boggs J; Dvorak LK; Letavic MA; Maryanoff BE; Carruthers NI; Bonaventure P; Lovenberg TW
Eur J Pharmacol; 2008 Jun; 587(1-3):141-6. PubMed ID: 18499098
[TBL] [Abstract][Full Text] [Related]
7. Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists.
Micheli F; Arista L; Bertani B; Braggio S; Capelli AM; Cremonesi S; Di-Fabio R; Gelardi G; Gentile G; Marchioro C; Pasquarello A; Provera S; Tedesco G; Tarsi L; Terreni S; Worby A; Heidbreder C
J Med Chem; 2010 Oct; 53(19):7129-39. PubMed ID: 20839775
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of enantiomerically pure milnacipran analogs and inhibition of dopamine, serotonin, and norepinephrine transporters.
Roggen H; Kehler J; Stensbøl TB; Hansen T
Bioorg Med Chem Lett; 2007 May; 17(10):2834-7. PubMed ID: 17350257
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.
Kotturi SV; Jiang S; Chang AC; Abraham P; Navarro HA; Kuhar MJ; Carroll FI
J Med Chem; 2005 Nov; 48(23):7437-44. PubMed ID: 16279803
[TBL] [Abstract][Full Text] [Related]
10. 1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.
Micheli F; Arista L; Bonanomi G; Blaney FE; Braggio S; Capelli AM; Checchia A; Damiani F; Di-Fabio R; Fontana S; Gentile G; Griffante C; Hamprecht D; Marchioro C; Mugnaini M; Piner J; Ratti E; Tedesco G; Tarsi L; Terreni S; Worby A; Ashby CR; Heidbreder C
J Med Chem; 2010 Jan; 53(1):374-91. PubMed ID: 19891474
[TBL] [Abstract][Full Text] [Related]
11. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
Jin ZL; Gao N; Zhou D; Chi MG; Yang XM; Xu JP
Pharmacol Biochem Behav; 2012 Jan; 100(3):431-9. PubMed ID: 22005599
[TBL] [Abstract][Full Text] [Related]
12. 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.
Zhang P; Terefenko EA; Bray J; Deecher D; Fensome A; Harrison J; Kim C; Koury E; Mark L; McComas CC; Mugford CA; Trybulski EJ; Vu AT; Whiteside GT; Mahaney PE
J Med Chem; 2009 Sep; 52(18):5703-11. PubMed ID: 19722525
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and monoamine uptake inhibition of conformationally constrained 2beta-carbomethoxy-3beta-phenyl tropanes.
Riss PJ; Hummerich R; Schloss P
Org Biomol Chem; 2009 Jul; 7(13):2688-98. PubMed ID: 19532984
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of meperidine analogues at monoamine transporters.
Lomenzo SA; Rhoden JB; Izenwasser S; Wade D; Kopajtic T; Katz JL; Trudell ML
J Med Chem; 2005 Mar; 48(5):1336-43. PubMed ID: 15743177
[TBL] [Abstract][Full Text] [Related]
15. Caulis Sinomenii extracts activate DA/NE transporter and inhibit 5HT transporter.
Zhao G; Bi C; Qin GW; Guo LH
Exp Biol Med (Maywood); 2009 Aug; 234(8):976-85. PubMed ID: 19491370
[TBL] [Abstract][Full Text] [Related]
16. Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.
Froimowitz M; Gu Y; Dakin LA; Nagafuji PM; Kelley CJ; Parrish D; Deschamps JR; Janowsky A
J Med Chem; 2007 Jan; 50(2):219-32. PubMed ID: 17228864
[TBL] [Abstract][Full Text] [Related]
17. An extended study of dimeric phenyl tropanes.
Nielsen S; Pedersen CM; Hansen SG; Petersen MD; Sinning S; Wiborg O; Jensen HH; Bols M
Bioorg Med Chem; 2009 Jul; 17(14):4900-9. PubMed ID: 19560930
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.
Zeng F; Jarkas N; Owens MJ; Kilts CD; Nemeroff CB; Goodman MM
Bioorg Med Chem Lett; 2006 Sep; 16(17):4661-3. PubMed ID: 16784855
[TBL] [Abstract][Full Text] [Related]
19. The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.
Kolaczynska KE; Thomann J; Hoener MC; Liechti ME
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361040
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
